196 related articles for article (PubMed ID: 32829329)
1. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
Klimek L; Price D; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
Int Arch Allergy Immunol; 2020; 181(10):754-764. PubMed ID: 32829329
[TBL] [Abstract][Full Text] [Related]
2. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
Kaulsay R; Nguyen DT; Kuhl HC
Immun Inflamm Dis; 2018 Dec; 6(4):456-464. PubMed ID: 30306729
[TBL] [Abstract][Full Text] [Related]
3. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
Haahr PA; Jacobsen C; Christensen ME
Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
[TBL] [Abstract][Full Text] [Related]
4. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.
Agache I; Doros IC; Leru PM; Bucur I; Poenaru M; Sarafoleanu C
Rhinology; 2018 Mar; 56(1):33-41. PubMed ID: 28942457
[TBL] [Abstract][Full Text] [Related]
5. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
Scadding G; Price D; El-Shanawany T; Ahmed S; Ray J; Sargur R; Kumar N
BMJ Open; 2017 Apr; 7(4):e014777. PubMed ID: 28442578
[TBL] [Abstract][Full Text] [Related]
6. Control of allergic rhinitis with MP-AzeFlu: a noninterventional study of a Swedish cohort.
Stjarne P; Strand V; Theman K; Ehnhage A
Rhinology; 2019 Aug; 57(4):279-286. PubMed ID: 30938376
[TBL] [Abstract][Full Text] [Related]
7. MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study.
Klimek L; Bachert C; Stjärne P; Dollner R; Larsen P; Haahr P; Agache I; Scadding G; Price D
Allergy Asthma Proc; 2016 Sep; 37(5):376-86. PubMed ID: 27657521
[TBL] [Abstract][Full Text] [Related]
8. Intranasal spray medications for maintenance therapy of allergic rhinitis.
Berger WE; Meltzer EO
Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
Berger W; Meltzer EO; Amar N; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Bousquet J
Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
[TBL] [Abstract][Full Text] [Related]
10. Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
Bousquet J; Meltzer EO; Couroux P; Koltun A; Kopietz F; Munzel U; Kuhl HC; Nguyen DT; Salapatek AM; Price D
J Allergy Clin Immunol Pract; 2018; 6(5):1726-1732.e6. PubMed ID: 29425904
[TBL] [Abstract][Full Text] [Related]
11. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis.
van Weissenbruch R; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; Kuhl HC; Pohl W; Scadding GK; Price D; Mullol J
J Asthma Allergy; 2020; 13():633-645. PubMed ID: 33293835
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu.
Dollner R; Lorentz Larsen P; Dheyauldeen S; Steinsvåg S
Allergy Rhinol (Providence); 2017 Oct; 8(3):148-156. PubMed ID: 29070272
[TBL] [Abstract][Full Text] [Related]
13. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
Klimek L; Berger WE; Bousquet J; Keith PK; Smith P; Sole D; Scadding G; Kuhl HC; Nguyen DT; Kopietz F; Koltun A
Int Arch Allergy Immunol; 2021; 182(11):1026-1035. PubMed ID: 34082425
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
Klimek L; Demoly P; Price D
Expert Rev Clin Pharmacol; 2016; 9(5):705-14. PubMed ID: 26839083
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.
Klimek L; Bachert C; Mösges R; Munzel U; Price D; Virchow JC; Wahn U; Bousquet J
Allergy Asthma Proc; 2015; 36(1):40-7. PubMed ID: 25562555
[TBL] [Abstract][Full Text] [Related]
16. Real-Life Effectiveness of MP-AzeFlu (Dymista
Stjärne P; Nguyen DT; Kuhl HC
Pragmat Obs Res; 2023; 14():1-11. PubMed ID: 36628265
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis.
Zhong Z; Xun Y; Shi X; Guan B; Wang M
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2457-2464. PubMed ID: 34415405
[TBL] [Abstract][Full Text] [Related]
18. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.
Price D; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
Clin Mol Allergy; 2020; 18():15. PubMed ID: 32782442
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
[TBL] [Abstract][Full Text] [Related]
20. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
Berger W; Bousquet J; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Wahn U
Allergy; 2016 Aug; 71(8):1219-22. PubMed ID: 27043452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]